Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation.

Author: ArtisKathryn, BaumannChristina, DeffebachMark, FuRongwei, HumphreyLinda L, MitchellJennifer Priest, PappasMiranda, SlatoreChristopher G, ZakherBernadette

Paper Details 
Original Abstract of the Article :
BACKGROUND: Lung cancer is the leading cause of cancer-related death in the United States. Because early-stage lung cancer is associated with lower mortality than late-stage disease, early detection and treatment may be beneficial. PURPOSE: To update the 2004 review of screening for lung cancer for...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.7326/0003-4819-159-6-201309170-00690

データ提供:米国国立医学図書館(NLM)

Lung Cancer Screening: A Tale of Two Cities

This comprehensive review explores the effectiveness and potential harms of using low-dose computed tomography (LDCT) to screen for lung cancer. The research summarizes findings from multiple studies, revealing that LDCT screening can significantly reduce lung cancer and all-cause mortality, although it also carries risks such as radiation exposure and overdiagnosis.

Navigating the Landscape of Lung Cancer Screening

The review provides a balanced perspective on the benefits and risks of LDCT screening, highlighting the importance of individualized decision-making based on factors such as smoking history, age, and overall health.

Protecting Our Lungs: A Journey Through the Respiratory Desert

This research underscores the importance of careful consideration when deciding whether to undergo lung cancer screening. Just as a desert traveler must weigh the risks and rewards of their journey, individuals must engage in informed discussions with their physicians to determine the best course of action for their lung health.

Dr.Camel's Conclusion

The decision to undergo lung cancer screening is a complex one, much like navigating a vast and potentially treacherous desert. This review provides valuable information to help individuals make informed decisions, weighing the potential benefits of early detection against the risks of false-positive results and radiation exposure. It's a reminder that navigating the realm of preventive healthcare requires careful consideration, open communication with medical professionals, and a commitment to understanding our own health journey.

Date :
  1. Date Completed 2013-12-11
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

23897166

DOI: Digital Object Identifier

10.7326/0003-4819-159-6-201309170-00690

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.